CorMedix Inc. (CRMD)
NASDAQ: CRMD · Real-Time Price · USD
6.46
+0.16 (2.54%)
At close: Mar 6, 2026, 4:00 PM EST
6.37
-0.09 (-1.39%)
After-hours: Mar 6, 2026, 7:59 PM EST
CorMedix Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Revenue | 311.71 | 43.47 | - | 0.07 | 0.19 | Upgrade
|
| Revenue Growth (YoY) | 617.03% | - | - | -65.74% | -20.19% | Upgrade
|
| Cost of Revenue | 22.09 | 3.03 | - | 0 | 0.15 | Upgrade
|
| Gross Profit | 289.62 | 40.44 | - | 0.06 | 0.04 | Upgrade
|
| Selling, General & Admin | 96.07 | 58.7 | 35.8 | 20.01 | 16.35 | Upgrade
|
| Research & Development | 19.33 | 3.94 | 13.16 | 10.68 | 13.13 | Upgrade
|
| Amortization of Goodwill & Intangibles | 13.87 | 0.16 | - | - | - | Upgrade
|
| Operating Expenses | 129.28 | 62.79 | 48.96 | 30.69 | 29.48 | Upgrade
|
| Operating Income | 160.34 | -22.36 | -48.96 | -30.62 | -29.44 | Upgrade
|
| Interest Expense | -2.78 | -0.04 | -0.03 | -0.03 | -0.02 | Upgrade
|
| Interest & Investment Income | 3.85 | 2.58 | 2.68 | 0.33 | 0.01 | Upgrade
|
| Currency Exchange Gain (Loss) | -0.05 | -0.03 | -0.03 | 0.04 | -0.02 | Upgrade
|
| Other Non Operating Income (Expenses) | - | 0.52 | - | - | - | Upgrade
|
| EBT Excluding Unusual Items | 161.35 | -19.33 | -46.34 | -30.29 | -29.46 | Upgrade
|
| Merger & Restructuring Charges | -10.2 | - | - | - | - | Upgrade
|
| Gain (Loss) on Sale of Investments | 5.36 | - | - | - | - | Upgrade
|
| Other Unusual Items | -6.5 | - | - | - | - | Upgrade
|
| Pretax Income | 150.02 | -19.33 | -46.34 | -30.29 | -29.46 | Upgrade
|
| Income Tax Expense | -13.04 | -1.4 | - | -0.59 | -1.25 | Upgrade
|
| Net Income | 163.06 | -17.93 | -46.34 | -29.7 | -28.21 | Upgrade
|
| Preferred Dividends & Other Adjustments | 0.99 | - | - | - | - | Upgrade
|
| Net Income to Common | 162.07 | -17.93 | -46.34 | -29.7 | -28.21 | Upgrade
|
| Shares Outstanding (Basic) | 72 | 59 | 51 | 40 | 38 | Upgrade
|
| Shares Outstanding (Diluted) | 80 | 59 | 51 | 40 | 38 | Upgrade
|
| Shares Change (YoY) | 36.41% | 15.65% | 26.39% | 6.93% | 31.87% | Upgrade
|
| EPS (Basic) | 2.25 | -0.30 | -0.91 | -0.74 | -0.75 | Upgrade
|
| EPS (Diluted) | 2.04 | -0.30 | -0.91 | -0.74 | -0.75 | Upgrade
|
| Free Cash Flow | 172.79 | -50.73 | -38.74 | -24.58 | -22.58 | Upgrade
|
| Free Cash Flow Per Share | 2.15 | -0.86 | -0.76 | -0.61 | -0.60 | Upgrade
|
| Gross Margin | 92.91% | 93.02% | - | 94.29% | 22.00% | Upgrade
|
| Operating Margin | 51.44% | -51.43% | - | -46819.91% | -15417.51% | Upgrade
|
| Profit Margin | 51.99% | -41.24% | - | -45409.90% | -14774.70% | Upgrade
|
| Free Cash Flow Margin | 55.43% | -116.70% | - | -37573.53% | -11826.24% | Upgrade
|
| EBITDA | 174.89 | -22.05 | -48.89 | -30.54 | -29.38 | Upgrade
|
| EBITDA Margin | 56.11% | -50.71% | - | - | - | Upgrade
|
| D&A For EBITDA | 14.55 | 0.31 | 0.07 | 0.08 | 0.06 | Upgrade
|
| EBIT | 160.34 | -22.36 | -48.96 | -30.62 | -29.44 | Upgrade
|
| EBIT Margin | 51.44% | -51.43% | - | - | - | Upgrade
|
| Revenue as Reported | 311.71 | 43.47 | - | - | - | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.